The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMurray Income Trust Regulatory News (MUT)

Share Price Information for Murray Income Trust (MUT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 863.00
Bid: 861.00
Ask: 865.00
Change: 8.00 (0.94%)
Spread: 4.00 (0.465%)
Open: 861.00
High: 863.00
Low: 857.00
Prev. Close: 855.00
MUT Live PriceLast checked at -
Murray Income is an Investment Trust

To achieve a high and growing income combined with capital growth through investment in a portfolio principally of UK equities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

6 Mar 2024 07:00

RNS Number : 6893F
Murray Income Trust PLC
06 March 2024
 

Murray Income Trust PLC

Half Yearly Report 31 December 2023

An investment trust founded in 1923 aiming for high and growing income with capital growth.

 

Investment Objective

The Company aims for a high and growing income combined with capital growth through investment in a portfolio principally of UK equities

Performance Highlights

Net asset value total returnAB ?

?

Share price total returnA ?

Six months ended 31 December 2023

?

?

Six months ended 31 December 2023

?

+4.5% ?

?

+6.2% ?

Year ended 30 June 2023

+8.8%

?

Year ended 30 June 2023

+4.9%

?

?

?

?

?

Benchmark total return

?

?

Ongoing chargesA

?

Six months ended 31 December 2023

?

?

Forecast year to 30 June 2024

?

+5.2% ?

?

0.51% ?

Year ended 30 June 2023

+7.9%

?

Year ended 30 June 2023

0.50%

?

?

?

?

?

Earnings per share (revenue)

?

?

Dividend per Ordinary share

?

Six months ended 31 December 2023

?

?

Year ended 30 June 2023

?

14.2p ?

?

37.50p ?

Six months ended 31 December 2022

16.3p

?

Year ended 30 June 2022

36.00p

?

?

?

?

?

Discount to net asset valueAB

?

?

Dividend yieldA

?

As at 31 December 2023

?

?

As at 31 December 2023

?

6.9% ?

?

4.3% ?

As at 30 June 2023

8.2%

?

As at 30 June 2023

4.5%

A Considered to be an Alternative Performance Measure. ? ? ? ?

B With debt at fair value. ? ? ?

?

 

Net asset value per share B

At 30 June (*31 December) - pence

2019

887.8

2020

807.7

2021

935.7

2022

871.0

2023

911.7

2023*

929.4

 

Dividends per share

Year ended 30 June - pence

2019

34.00

2020

34.25

2021

34.50

2022

36.00

2023

37.50

 

Mid-Market price per share

At 30 June (*31 December) - pence

2019

850.0

2020

768.0

2021

871.0

2022

832.0

2023

837.0

2023*

865.0

 

Financial Calendar, Dividends and Highlights

 

Financial Calendar

Payment dates of quarterly dividends

March, June, September, December

Financial year end

30 June

Expected announcement date of annual results

September

Annual General Meeting (London)

5 November 2024

Dividends

?

Rate

Ex-dividend date

Record date

Payment date

First interim

9.50p

16 Nov 2023

17 Nov 2023

14 Dec 2023

Second interim

9.50p

15 Feb 2024

16 Feb 2024

14 Mar 2024

Third interim

9.50p

16 May 2024

17 May 2024

13 Jun 2024

 

 

Chair's Statement

 

"The Company has prospered over the years through multiple economic, social and political crises. There are many good reasons to believe that it will continue to thrive in the years to come."

Peter Tait, Chair

 

Having taken over as Chair of Murray Income Trust plc (the "Company") at the Centenary Annual General Meeting ("AGM") in November 2023, I am delighted to present my first Half-Yearly Report for the Company for the six months ended 31 December 2023 (the "Period"). Last year was historic for the Company. Not only did it celebrate its centenary, it also increased its annual dividend for the 50th consecutive year, giving it one of the longest records of progressive dividend growth in the investment trust sector. Our aim is to continue the trend of capital and income growth which we have seen over many years - and a dividend yield of 4.5% at 31 December 2023 is a good place to start. The Board also welcomed the announcement by abrdn plc, in December 2023, that it had commenced a programme whereby it would purchase shares in the Company equivalent to six months' management fees.

Performance

The Company's net asset value ("NAV") per share (with debt at fair value) increased by 4.5% over the Period, as compared to the rise of 5.2% in the FTSE All-Share Index (the "Benchmark"), both figures in total return terms.  The fair value of the Company's long-term debt was adversely affected by interest rate movements during the Period, which weighed on the Company's NAV return. The share price total return was 6.2% following a narrowing of the discount from 8.2% to 6.9%.

 

?

 Year ended

 3 years ended

 5 years ended

?

 31 December 2023

 31 December 2023

 31 December 2023

Cumulative Performance (total return)

%

%

%

Share price

7.3

17.4

47.1

Net asset value per Ordinary shareA

8.9

21.6

46.0

FTSE All-Share Index

7.9

28.1

37.7

A With debt at fair value

Investment Team

abrdn is our appointed investment management company. Charles Luke has been our lead portfolio manager since 2006 and works alongside co-manager Iain Pyle and Rhona Millar as part of abrdn's Developed Markets Equities team.

Investment Process

Our Manager's investment process is best summarised as a search for good quality companies at attractive valuations. The Manager defines a quality company as one capable of strong and predictable cash generation, sustainably high returns on capital and with attractive growth opportunities over the longer term. These typically result from a sound business model, a robust balance sheet, good management and strong environmental, social and governance characteristics.

Annual General Meeting ("AGM")

The 2023 AGM for the Company was held in Glasgow on 7 November 2023, celebrating the centenary of its launch in that city in 1923. The Company was initially called "The Second Scottish Western Investment Company", changing its name to Murray Income Trust plc in 1984, at which time it also altered its remit to invest for a high and growing income from a portfolio of predominantly UK equities. It was encouraging to see such a strong and enthusiastic turn-out for this special event. 

A further centenary event for the Company was held in December 2023 when I, as Chair, had the pleasure of officiating at the closing ceremony of the London Stock Exchange, where I was joined by most of the Board, representatives from abrdn and our corporate broker, as well as the three most recent former Chairs.

Board

Following the retirement of Neil Rogan and resignation of Merryn Somerset Webb at the conclusion of the 2023 AGM, the Board was delighted to announce the appointment of Angus Franklin as a new non-executive director from 1 January 2024. Angus joined the Board following a distinguished career in various senior investment roles with Bailie Gifford & Co. Having, myself, assumed the role as Chair, my former position as Senior Independent Director is now held by Alan Giles who has been a Board member for three years. The other members of the Board are Stephanie Eastment, as Chair of the Audit Committee, and Nandita Sahgal Tully, who specialises in investment and ESG matters.

Dividend

The dividend for the year ended 30 June 2023 was increased by 4.2% to 37.5p per share, giving a year-end historic yield for the Company of 4.5%. Whilst intending to maintain the Company's progressive dividend policy for the year to 30 June 2024, the Board also decided to rebalance the quarterly dividend pay-outs, allowing shareholders to access more quickly and more evenly their dividend income throughout the year. As announced in November 2023, the first three dividend payments for the year ended 30 June 2024 are 9.5p per share (previously 8.25p per share). As a result, the fourth interim dividend will be lower than that for last year but it is anticipated to be not less than 9.5p per share, giving an expected total for the year of a minimum of 38.0p per share.

Share Capital

The Board constantly monitors the level of the share price discount to NAV and buys back shares when market conditions suggest that this may reduce discount volatility. In addition, all share buybacks are at a discount to NAV and are accretive to the Company. To that end, the Company bought back 3,686,219 Ordinary shares of 25p into treasury during the Period, representing 3.3% of shares in issue at 30 June 2023. As a result, at 31 December 2023, the Company had 108,033,782 Ordinary shares of 25p in issue with voting rights and an additional 11,495,750 shares held in treasury.

Environmental, Social and Governance ("ESG")

ESG considerations are deeply embedded into the company analysis carried out by our Manager with the aim of mitigating risk and enhancing returns. There is frequent dialogue with investee companies, focused on ensuring that the companies in the portfolio are acting in the best long-term interests of both their shareholders and society at large. By way of example, the Investment Manager's Report describes engagement during the Period with Standard Chartered, National Grid and London Stock Exchange Group.

It is important to note that the policy pursued by our Manager on our behalf is dynamic rather than static. ESG conclusions can evolve if the inputs change: for example, one might reassess Russia's invasion of Ukraine or the conflict in the Middle East and conclude that the social factor of national security and safety is more important now than previously considered.

Update

At 29 February 2024 (the latest practicable date prior to approval of this Report), the net asset value per share (with debt at fair value) and share price were 906.98p and 821.00p, respectively. Accordingly, for the period from 31 December 2023 to 29 February 2024, the net asset value total return (with debt at fair value) and share price total return were -1.4% and -4.0%, respectively, while the Benchmark total return was -1.1%.

Outlook

The previous calendar year (2023) was a mixed bag for equity markets with a strong recovery in technology stocks, resulting in a 25% gain in the US S&P index, but a more modest 7.9% increase in the UK FTSE All-Share Index, the Company's own benchmark. With other non-UK markets also performing well during the year, the portfolio benefited from its near 20% exposure to overseas stocks including Accton Technology, Novo Nordisk and VAT Group, which each rose by more than 20% in the six months ended 31 December 2023.

As we turn our attention to 2024, one question I am asking myself is why has the UK market been a laggard and what might cause the situation to improve in the months and years ahead? There is, of course, never one definitive reason for market performance, but such reasons could include higher than anticipated inflation and interest rates, the impact of the Ukraine war on energy supply and utility bills, a lack of technology stocks in the Benchmark, a continuing Brexit hangover (dissuading foreign investors from the market) and the sharp reduction in equity exposure, particularly UK equity exposure, by UK Defined Benefit pension schemes. Information published by the Pensions and Lifetime Savings Association shows that, 20 years ago, UK Defined Benefit pension schemes invested about half of their assets in UK equities, but that this had fallen to only about 3% by 2023.

As a result, as noted in the Investment Manager's Report, the UK market now looks very cheap compared to its own history and to international markets. Of course, there will be headwinds along the way, but interest rate trends are usually very important for equity market movements. The anticipation of falling UK interest rates later this calendar year could attract the attention of potential investors, particularly given the appealing combination of a market dividend yield of 4.0% and forecast dividend and earnings growth in 2024, according to a Bloomberg consensus of estimates in January, of 9.2% and 10.1%, respectively, despite the lacklustre outlook for overall economic growth.

From a Murray Income shareholder perspective, your starting point is a higher yield of 4.6%, and the shares standing on a 9.5% discount to net asset value (as at the date of this Report, with debt at fair value). The potential, therefore, for positive returns from owning the Company's shares is encouraging, with a good yield and the capacity for earnings growth, together with a discount to net asset value at present. Markets can be blown off-course by many exogenous factors, and there remain significant risks in the current geo-political situation, emanating from the continuing Russian war in Ukraine, the current Middle East crisis, and tensions between China and both Taiwan and the USA, not to mention the fact that nearly half of the world's population will be participating in general elections during the course of 2024. But the Company has prospered over the years through multiple economic, social and political crises. There are many good reasons to believe that it will continue to thrive in the years to come. 

For a more detailed review of the UK market and the outlook for the Company's portfolio, please see the Investment Manager's Report.

Peter TaitChair5 March 2024

 

 

 

Investment Manager's Report

 

The Company generated a positive Net Asset Value ("NAV") per share (with debt at fair value) return of 4.5% for the six months ended 31 December 2023 (the "Period"). This underperformed the Company's Benchmark (the FTSE All-Share Index ) which returned 5.2% (both figures calculated on a total return basis).

From a style perspective, the portfolio's Quality bias continued to be a headwind to performance (albeit to a lesser extent than during the first half of the calendar year) as the Value factor outperformed. In sector terms, the portfolio's overweight position in the Consumer Discretionary sector and underweight exposure to the Financials sector benefited performance. In contrast, the overweight position in the Industrials sector detracted from relative performance, as did the underweight exposure to the Basic Materials sector. The holdings in Sage, TotalEnergies and Vistry were the most beneficial to relative returns while the holdings in Rentokil Initial and Diageo detracted the greatest, relatively. Not holding Shell and Rolls-Royce also detracted from performance.

Two new holdings were purchased for the portfolio during the Period. The first addition was the leading global actuator business, Rotork, which has strong quality characteristics and under-appreciated growth opportunities. Drivers of growth include their electric actuator product which is used to reduce methane emissions in the Oil & Gas sector, which is increasingly a priority as the industry looks to meet emission reduction targets. The second new entrant was US-listed Mastercard, which we see as having attractive quality characteristics, including strong competitive positioning and high barriers to entry, as well as having multiple long-term growth opportunities. The Company's ability to own overseas holdings allows the portfolio to access an industry not available through the UK market. Further information on Rotork and Mastercard may be found in the case studies..

Three holdings were sold during the Period: Croda, where our conviction in the long-term strategy deteriorated, while the valuation remains high; Marshalls, where we had concerns around the trading environment and potential implications for the company's balance sheet; and Drax, due to increasing uncertainty around the long-term business model.

Other trading related to managing position sizes, reflecting conviction levels. In the utilities sector, National Grid was added to while SSE was reduced. In healthcare, we reduced Smith & Nephew and added to ConvaTec. In the mining sector, the position in BHP was reduced and proceeds reinvested in Anglo American. The holding in Mondi, which reached an agreement to sell its Russian business in September, was added to. The holdings in Rentokil Initial and Games Workshop were added to following trading statements which led to weakness in the shares, as we remain more positive on the longer-term outlooks for both companies. The holding in VAT Group was trimmed following strong share price performance, which made the valuation less attractive. The position in Vistry was reduced given it appears there is a low likelihood of dividend payments, with the company instead favouring buybacks. Further trades included adding to bp, Diageo, Intermediate Capital, L'Oréal, Oxford Instruments, Oversea-Chinese Banking Corp and RS Group while trimming AstraZeneca, Coca-Cola HBC, Inchcape, Novo Nordisk, RELX and Safestore.

We continued our measured option-writing programme which is based on our fundamental analysis of holdings in the portfolio. We believe that the option-writing strategy, which we have now employed for well over a decade, is of benefit to the Company by diversifying and modestly increasing the level of income generated and providing headroom to invest in companies with lower starting yields but better dividend and capital growth prospects. The Company also bought back shares, representing 3.3% of the shares in issue, during the Period.

One of the tenets of our investment philosophy is the belief that in order to grow dividends over the long term a company needs to grow its earnings and that high quality companies are best placed to do that. We believe that the portfolio is well positioned to do just this. Looking at the portfolio from a quantitative perspective at 31 December 2023, typical measures of portfolio quality such as returns measures and earnings stability were high in absolute terms and considerably better than the Benchmark (for example, in aggregate, the return on equity and return on assets of the portfolio holdings was 20.7% and 7.5% respectively, compared to the Benchmark at 15.8% and 5.3%, respectively). Furthermore, the portfolio generates a dividend yield approximately in line with the Benchmark. At 31 December 2023, the portfolio traded on a forward P/E multiple of 14.5x compared to the Benchmark on 11.5x: more expensive but to our minds a reasonable price to pay for a considerably better quality portfolio and one still very attractively valued in absolute terms.

Environmental, Social and Governance ("ESG")

ESG issues are discussed as part of our regular engagement with portfolio companies' management. However, we also engage on a variety of specific issues outside our regular meetings cycle. It should be noted that given the Quality threshold inherent in the portfolio, these meetings are rarely about issues for which we hold significant concerns. To provide some examples of the variety of engagements during the Period: firstly, we met with the Head of Sustainable Finance at Standard Chartered to discuss the steps the bank is taking to reach its sustainable finance targets. Secondly, we engaged with National Grid to discuss their approach to securing public consent among those communities that are likely to be affected by the construction of new infrastructure required to meet the electricity needs in a net-zero economy. Thirdly, we met with London Stock Exchange Group to discuss proposed changes to its remuneration policy.

Market and Economic Background

The UK equity market, as measured by the Benchmark, rose by 5.2% on a total return basis over the Period. The start was characterised by wavering optimism that signs of declines in inflation would bring an end to the rate hiking cycle which has been ongoing since 2022, while on the other hand concerns that the strength of economic data in the US would lead to further rate increases remained. In November 2023, confidence began to build that interest rates across major economies had peaked, leading to an end of year rally for equity markets. 

Performance at a sector level was mixed. Aerospace & defence and housebuilding companies performed well but some retail companies struggled. The more domestically focused FTSE 250 Index outperformed the FTSE 100 Index over the Period.

Domestic economic data was generally weak. UK economic activity continued to stagnate with GDP falling by 0.4% in the three months to December 2023, following a 0.1% decline in the three months to September 2023. Consumer confidence strengthened from historically low levels over the Period; conversely, employment data weakened with wage growth slowing and vacancies falling.

Inflation continued to decline from a peak of 11% in 2022, no longer looking like a significant international outlier. This led to a slowing in the pace of rate hikes over the Period, with the Bank of England ("BoE") raising rates by 0.25% in August 2023 but holding at 5.25% at each of the subsequent meetings. Despite the falls in inflation, the BoE Governor, Andrew Bailey, was quick to stress that rates would not be cut in the near future, reiterating the Bank's commitment to bring inflation back within its 2% target.

These inflation trends have been similar in the US and the Eurozone, where inflation fell more quickly than was expected. Central banks in those regions have also held rates flat since late summer. Economic growth in the US has been particularly robust, which led to increased optimism of a soft landing and a strong end to the Period for US markets, with the 'Magnificent 7' technology companies continuing to be strong. In China, economic activity data showed signs of bottoming and monetary and fiscal policy is expected to ease further. Energy prices ended the Period slightly higher, rising strongly on OPEC production cuts and following the Israel-Hamas conflict, but then falling back on concerns about slowing global growth.

Outlook

We expect the sharp monetary policy tightening over the past 18 months to lead to a slowdown in global economic growth in 2024. For the UK, we currently forecast zero GDP growth in 2024. Inflation is expected to continue to trend downwards but still remains higher than BoE targets and a key focus for markets will be on interest rate cutting cycles and when and how quickly they get under way. The most recent Consumer Prices Index data for the 12 months to January 2024 indicated a reading of 4.2%. At its January 2024 meeting, six members of the BoE's 9-strong Monetary Policy Committee voted to maintain interest rates unchanged, at 5.25%. abrdn's economists expect the BoE to start cutting rates in mid-2024.

Political risk, with a number of significant likely elections including the US and UK this calendar year, and geopolitical risk with, in particular, increased tensions in the Middle East, are likely to remain elevated.

The portfolio is full of high quality, predominantly global businesses capable of delivering appealing long term earnings and dividend growth at a modest valuation. Our focus on quality companies should provide protection through a downturn: those companies with pricing power, high margins and strong balance sheets are better placed to navigate a more challenging economic environment and emerge in a strong position. Furthermore, these quality characteristics are helpful in underpinning the portfolio's income generation.

The valuations of UK-listed companies remain attractive on a relative and absolute basis. Apart from the global financial crisis in 2008/2009 the UK's price/earnings multiple of 10.4x is near its lowest point for 30 years. The UK stockmarket is cheap in absolute terms, relative to history and also relative to global equities. Investors are earning global income at a knock-down price. Moreover, the dividend yield of the UK market remains at an appealing premium to other regional equity markets.

In summary, we feel optimistic that our long-term focus on investments in high quality companies with robust competitive positions and strong balance sheets, which are led by experienced management teams, will be capable of delivering premium earnings and dividend growth.

Charles Luke and Iain Pyle,abrdn Investments Limited5 March 2024

 

Ten Largest Investments

 

As at 31 December 2023

Relx

?

AstraZeneca

Relx is a global provider of information and analytics for professionals and businesses across a number of industries including scientific, technical, medical and law.The company offers resilient earnings combined with long term structural growth opportunities.

?

AstraZeneca researches, develops, produces and markets pharmaceutical products. With a significant focus on oncology and rare diseases the company offers appealing growth potential over the medium term.

?

?

?

Unilever

?

Diageo

Unilever is a global consumer goods company supplying food, home and personal care products. The company has a portfolio of strong brands including Dove, Knorr, Axe and Persil. Over half of the company's sales are to developing and emerging markets.

?

Diageo produces, distills and markets alcoholic beverages including vodkas, whiskies, tequilas, gins and beer. The company should benefit from attractive long term drivers such as population and income growth, and premiumisation. The company has a variety of very strong brands and faces very limited private label competition.

?

?

?

TotalEnergies

?

bp

TotalEnergies is a broad energy company that produces and markets fuels, natural gas and electricity. It is a leader in the sector's energy transition with an attractive pipeline of renewable assets.

?

bp is a fully integrated energy company involved in exploration, production, refining, transportation and marketing of oil and natural gas. The company provides an attractive dividend yield and is well placed for the energy transition.

?

?

?

Sage

?

London Stock Exchange

Sage is a market leading software business focused on accounting, payroll and payments. The company has a strong product suite and is well placed to benefit from the software automation of its small and mid-sized customers over the medium term.

?

London Stock Exchange is a diversified global financial markets infrastructure and data business. The company is highly cash generative and very well placed to benefit from increased spend on data services.

?

?

?

BHP

?

Experian

BHP Group (formerly BHP Billiton) is a diversified resources group with a global portfolio of high quality assets particularly iron ore and copper. The company combines an appealing dividend yield combined with a strong balance sheet.

?

Experian is a market leader in the provision of credit and marketing services. It maintains one of the largest credit bureaus and offers specialist analytical solutions for credit scoring, risk management and application processing across a number of different markets including financial services, health, retail and government.

 

 

Investment Portfolio

 

As at 31 December 2023 ? ? ? ?

?

?

?

?

Total

?

?

?

Valuation

 investments

Investment

Sector

Country

£'000

%

Relx

Media

UK

61,004

5.7

AstraZeneca

Pharmaceuticals and Biotechnology

UK

55,071

5.1

Unilever

Personal Care Drug and Grocery Stores

UK

52,113

4.8

Diageo

Beverages

UK

47,636

4.4

TotalEnergies

Oil, Gas and Coal

France

40,680

3.8

bp

Oil, Gas and Coal

UK

39,856

3.7

Sage

Software and Computer Services

UK

38,061

3.5

London Stock Exchange

Finance and Credit Services

UK

37,592

3.5

BHP

Industrial Metals and Mining

UK

32,470

3.0

Experian

Industrial Support Services

UK

31,113

2.9

Top ten investments

?

?

435,596

40.4

Intermediate Capital

Investment Banking and Brokerage Services

UK

28,114

2.6

National Grid

Gas Water and Multi-utilities

UK

27,495

2.5

Oversea-Chinese Banking

Banks

Singapore

25,087

2.3

Anglo American

Industrial Metals and Mining

UK

24,210

2.2

Close Brothers

Banks

UK

24,050

2.2

Rentokil Initial

Industrial Support Services

UK

23,951

2.2

SSE

Electricity

UK

22,856

2.1

Howden Joinery

Retailers

UK

22,677

2.1

Inchcape

Industrial Support Services

UK

22,352

2.1

Convatec

Medical Equipment and Services

UK

22,209

2.1

Top twenty investments

?

?

678,597

62.8

Microsoft

Software and Computer Services

United States

19,682

1.8

Nordea Bank

Banks

Sweden

18,938

1.8

Safestore Holdings

Real Estate Investment Trusts

UK

18,767

1.7

Oxford Instruments

Electronic and Electrical Equipment

UK

18,653

1.7

Vistry

Household Goods and Home Construction

UK

17,490

1.6

M&G

Investment Banking and Brokerage Services

UK

17,269

1.6

Genus

Pharmaceuticals and Biotechnology

UK

16,344

1.5

Mondi

General Industrials

UK

15,011

1.4

Games Workshop

Leisure Goods

UK

14,894

1.4

Novo-Nordisk

Pharmaceuticals and Biotechnology

Denmark

13,987

1.3

Top thirty investments

?

?

849,632

78.6

OSB

Finance and Credit Services

UK

13,987

1.3

Hiscox

Non-life Insurance

UK

13,523

1.3

Nestlé

Food Producers

Switzerland

13,157

1.2

Kone

Industrial Engineering

Finland

12,983

1.2

L'Oréal

Personal Care Drug and Grocery Stores

France

12,664

1.2

Direct Line Insurance

Non-life Insurance

UK

12,645

1.2

VAT

Electronic and Electrical Equipment

Switzerland

12,324

1.1

RS

Industrial Support Services

UK

12,245

1.1

Standard Chartered

Banks

UK

11,788

1.1

Genuit

Construction and Materials

UK

11,711

1.1

Top forty investments

?

?

976,659

90.4

Coca-Cola HBC

Beverages

UK

11,329

1.1

Rotork

Industrial Engineering

UK

11,142

1.0

Accton Technology

Telecommunications Equipment

Taiwan

10,674

1.0

LVMH

Personal Goods

France

10,579

1.0

Telenor

Telecommunications Service Providers

Norway

10,507

1.0

Roche

Pharmaceuticals and Biotechnology

Switzerland

9,397

0.9

Smith & Nephew

Medical Equipment and Services

UK

8,801

0.8

Mastercard

Finance and Credit Services

United States

8,231

0.8

GSK

Pharmaceuticals and Biotechnology

UK

8,138

0.8

Chesnara

Life Insurance

UK

6,901

0.6

Top fifty investments

?

?

1,072,358

99.4

Moonpig

Retailers

UK

6,185

0.6

Total investments (51)

?

?

1,078,543

100.0

Ordinary shares unless otherwise stated. ? ? ? ?

 

 

Investment Case Studies

 

Mastercard

Mastercard, the US-listed technology company in the global payments industry, was added to the portfolio in the six months ended 31 December 2023. The company has an approximate market capitalisation of $430bn and the overseas-listed holding adds exposure to a market segment that would be difficult for the portfolio to access through the UK market.

Mastercard's core business is consumer payments processing for credit and debit cards and the business model is a beneficiary of the shift from cash to electronic payments, which will continue to drive earnings growth. Furthermore, business to business flows are also an attractive area for growth. In addition, the company's value-added services business (which includes cyber-security and analytics insights into consumer spending), provides a further avenue for expansion.

The company has a significant competitive advantage, driven by the 'network effect' of issuing over a billion credit cards, accepted by millions of merchants and many financial institutions, as well as the security capabilities enabled by the extensive data these transactions generate. The dividend yield of the stock is relatively modest compared to some of the other holdings in the portfolio but we see potential for strong long-term dividend growth supported by a share buy-back programme.

 

Rotork

A constituent of the FTSE 250 Index, with a market capitalisation of approximately £2.7bn, Rotork was introduced to the portfolio during the six months ended 31 December 2023. Rotork operates in the valve industry and is the global leading manufacturer of actuators, selling products and services to industries including Oil & Gas, Industrials, Chemicals, Water and Power.

In the short term, the recovery in oil and gas capex budgets should be a tailwind for the company. In the longer term, the company has a part to play in the energy transition helping to remove methane emissions in oil and gas wells while also enabling the growth of hydrogen and carbon capture, utilisation and storage (CCUS). Rotork is conservatively managed and has strong quality characteristics, such as, for example, attractive margins, a high return on capital employed, high barriers to entry (such as strong brand resonance, certification, reliability and field service) and a net cash balance sheet.

The company's dividend has good scope to grow as earnings increase through a mixture of revenue growth, product mix and operating leverage while the strong balance sheet provides an opportunity for inorganic growth.

 

Interim Board Report

Principal Risks and Uncertainties

The Board regularly reviews the principal risks and uncertainties which it has identified, together with the delegated controls it has established to manage the risks and address the uncertainties. These are considered to be materially unchanged as at 31 December 2023, as compared to 30 June 2023. The principal risks and uncertainties are set out in detail on pages 18 to 22 of the Company's Annual Report for the year ended 30 June 2023 ("Annual Report 2023") which is available on the Company's website. The Annual Report 2023 also contains, in note 18 to the Financial Statements, an explanation of other risks relating to the Company's investment activities, specifically market risk, liquidity risk and credit risk, and a note of how these risks are managed.

Related Party Transactions

Under Generally Accepted Accounting Practice (UK Accounting Standards and applicable law), the Company has identified the Directors as related parties. No other related parties have been identified. There have been no related party transactions that have had a material effect on the financial position of the Company.

Going Concern

The factors which have an impact on the Company's status as a going concern are set out in the Going Concern section of the Directors' Report on pages 42 and 43 of the Annual Report 2023. As at 31 December 2023, there had been no material changes to these factors.

The Board has set limits for borrowing and regularly reviews the level of any gearing, cash flow projections and compliance with covenants associated with the Senior Loan Notes and bank facilities. As at 31 December 2023, in addition to the £40m 10 year Senior Loan Notes 2027 and £60m 10 year Senior Loan Notes 2029, £6.5m of the Company's three-year £50m multi-currency revolving bank credit facility (the "Facility") was drawn down. On the expiry of the Facility in October 2024, the Company would expect to continue to access a credit facility. However, should acceptable terms for a new credit facility not be forthcoming at that time, any outstanding borrowing will be repaid through the proceeds of sales of portfolio holdings.

The Directors are mindful of the principal risks and uncertainties disclosed above and, having reviewed forecasts detailing revenue and liabilities, they believe that the Company has adequate financial resources to continue its operational existence for the foreseeable future. Accordingly, the Directors believe that it is appropriate to continue to adopt the going concern basis of accounting in preparing the Financial Statements.

US Executive Order No. 14032

The Board confirms that the Company has not and does not intend to invest in any of the companies designated as "Chinese Military-Industrial Complex Companies" by the US Executive Order No. 14032.

Statement of Directors' Responsibilities

The Directors are responsible for preparing the Half-Yearly Financial Report in accordance with applicable law and regulations. The Directors confirm that to the best of their knowledge:

·  the condensed set of Financial Statements has been prepared in accordance with Financial Reporting Standard 104 (Interim Financial Reporting);

·  the Half-Yearly Board Report includes a fair review of the information required by rule 4.2.7R of the Disclosure Guidance and Transparency Rules (being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of Financial Statements and a description of the principal risks and uncertainties for the remaining six months of the financial year); and

·  the Half-Yearly Board Report includes a fair review of the information required by 4.2.8R (being related party transactions that have taken place during the first six months of the financial year and that have materially affected the financial position of the Company during that period; and any changes in the related party transactions described in the last Annual Report that could do so).

The Half-Yearly Financial Report for the six months ended 31 December 2023 comprises the Half-Yearly Board Report, the Directors' Responsibility Statement and the condensed set of Financial Statements.

For and on behalf of the BoardPeter TaitChair5 March 2024

Condensed Statement of Comprehensive Income (unaudited)

 

 

?

?

? Six months ended  ?

? Six months ended  ?

?

?

? 31 December 2023 ?

? 31 December 2022 ?

?

?

Revenue

Capital

Total

Revenue

Capital

Total

?

Notes

£'000

£'000

£'000

£'000

£'000

£'000

Gains on investments

?

-

32,687

32,687

-

22,014

22,014

Currency (losses)/gains

?

-

(59)

(59)

-

626

626

Income

2

17,364

-

17,364

20,869

-

20,869

Investment management fees

4, 13

(551)

(1,287)

(1,838)

(566)

(1,321)

(1,887)

Administrative expenses

?

(683)

-

(683)

(718)

-

(718)

Net return before finance costs and taxation

?

16,130

31,341

47,471

19,585

21,319

40,904

Finance costs

?

(385)

(897)

(1,282)

(359)

(837)

(1,196)

Net return before taxation

?

15,745

30,444

46,189

19,226

20,482

39,708

Taxation

5

(191)

-

(191)

(259)

-

(259)

Net return after taxation

?

15,554

30,444

45,998

18,967

20,482

39,449

?

?

?

?

?

?

?

?

Return per Ordinary share

6

14.2p

27.7p

41.9p

16.3p

17.6p

33.9p

?

?

?

?

The total column of this statement represents the profit and loss account of the Company prepared in accordance with FRS 102. The 'Revenue' and 'Capital' columns represent supplementary information prepared under guidance issued by the Association of Investment Companies. ? ? ? ? ? ? ?

All revenue and capital items in the above statement derive from continuing operations. ? ? ? ? ? ? ?

No operations were acquired or discontinued in the period. ? ? ? ? ? ? ?

The accompanying notes are an integral part of the condensed financial statements. ? ? ? ? ? ? ?

 

 

 

Condensed Statement of Financial Position (unaudited)

 

?

?

As at

As at

?

?

31 December 2023

30 June 2023

?

Notes

£'000

£'000

Fixed assets

?

?

?

Investments at fair value through profit or loss

?

1,078,543

1,098,311

?

?

?

?

Current assets

?

?

?

Other debtors and receivables

?

5,900

7,274

Cash and cash equivalents

?

24,568

15,115

?

?

30,468

22,389

?

?

?

?

Creditors: amounts falling due within one year

?

?

?

Derivative financial instruments

?

(1,371)

-

Other payables

?

(2,578)

(5,997)

Bank loans

7

(6,497)

(6,378)

?

?

(10,446)

(12,375)

Net current assets

?

20,022

10,014

Total assets less current liabilities

?

1,098,565

1,108,325

?

?

?

?

Creditors: amounts falling due after one year

?

?

?

2.51% Senior Loan Notes 2027

7

(39,948)

(39,941)

4.37% Senior Loan Notes 2029

7

(68,409)

(69,200)

?

?

(108,357)

(109,141)

Net assets

?

990,208

999,184

?

?

?

?

Capital and reserves

?

?

?

Share capital

8

29,882

29,882

Share premium account

?

438,213

438,213

Capital redemption reserve

?

4,997

4,997

Capital reserve

?

489,332

489,428

Revenue reserve

?

27,784

36,664

Total Shareholders' funds

?

990,208

999,184

?

?

?

?

Net asset value per Ordinary share

9

?

?

Debt at fair value

?

929.4p

911.7p

Debt at par value

?

916.6p

894.4p

?

?

?

?

The accompanying notes are an integral part of the condensed financial statements. ? ? ?

 

 

Condensed Statement of Changes in Equity (unaudited)

 

Six months ended 31 December 2023 ? ? ? ? ? ? ?

?

?

?

Share

Capital

?

?

?

?

?

Share

premium

redemption

Capital

Revenue

?

?

?

capital

account

reserve

reserve

reserve

Total

?

Notes

£'000

£'000

£'000

£'000

£'000

£'000

Balance at 1 July 2023

?

29,882

438,213

4,997

489,428

36,664

999,184

Net return after tax

?

-

-

-

30,444

15,554

45,998

Buyback of Ordinary shares for treasury

8

-

-

-

(30,540)

-

(30,540)

Dividends paid

3

-

-

-

-

(24,434)

(24,434)

Balance at 31 December 2023

?

29,882

438,213

4,997

489,332

27,784

990,208

?

?

?

?

?

?

?

?

?

?

?

?

?

?

?

?

?

?

?

?

?

?

?

?

Six months ended 31 December 2022 ? ? ? ? ? ? ?

?

?

?

Share

Capital

?

?

?

?

?

Share

premium

redemption

Capital

Revenue

?

?

?

capital

account

reserve

reserve

reserve

Total

?

Notes

£'000

£'000

£'000

£'000

£'000

£'000

Balance at 1 July 2022

?

29,882

438,213

4,997

502,672

33,491

1,009,255

Net return after tax

?

-

-

-

20,482

18,967

39,449

Buyback of Ordinary shares for treasury

8

-

-

-

(9,296)

-

(9,296)

Dividends paid

3

-

-

-

-

(22,614)

(22,614)

Balance at 31 December 2022

?

29,882

438,213

4,997

513,858

29,844

1,016,794

?

?

?

?

?

?

?

?

The accompanying notes are an integral part of the condensed financial statements. ? ? ? ? ? ? ?

 

 

 

Condensed Statement of Cash Flows (unaudited)

 

?

?

Six months ended

Six months ended

?

?

31 December 2023

31 December 2022

?

Notes

£'000

£'000

Operating activities

?

?

?

Net return before finance costs and taxation

?

47,471

40,904

Adjustments for

?

?

?

Increase in accrued expenses

?

115

1,114

Overseas withholding tax

?

(201)

(244)

Decrease in dividend income receivable

?

1,830

1,600

Increase in interest income receivable

?

(28)

(47)

Interest paid

?

(1,508)

(1,177)

Gains on investments

?

(32,687)

(22,014)

Amortisation of loan note expenses

?

7

6

Accretion of loan note book cost

?

(791)

(791)

Foreign exchange losses/(gains)

?

59

(626)

Increase in other debtors

?

(417)

(342)

Net cash inflow from operating activities

?

13,850

18,383

?

?

?

?

Investing activities

?

?

?

Purchases of investments

?

(62,488)

(112,528)

Sales of investments

?

113,005

135,999

Net cash inflow from investing activities

?

50,517

23,471

?

?

?

?

Financing activities

?

?

?

Dividends paid

3

(24,434)

(22,614)

Buyback of Ordinary shares for treasury

8

(30,540)

(9,296)

Repayment of bank loans

?

-

(6,755)

Draw down of bank loans

?

-

6,664

Net cash outflow from financing activities

?

(54,974)

(32,001)

Increase in cash

?

9,393

9,853

?

?

?

?

Analysis of changes in cash during the period

?

?

?

Opening balance

?

15,115

20,131

Effect of exchange rate fluctuations on cash held

?

60

875

Increase in cash as above

?

9,393

9,853

Closing balance

?

24,568

30,859

?

?

?

?

Represented by:

?

?

?

Cash at bank and in hand

?

4,675

4,786

Money market funds

?

19,893

26,073

?

?

24,568

30,859

?

?

?

?

The accompanying notes are an integral part of the condensed financial statements. ? ? ?

 

 

 

Notes to the Financial Statements

For the six months ended 31 December 2023

 

1.

Accounting policies

?

Basis of preparation. The condensed financial statements have been prepared in accordance with Financial Reporting Standard ("FRS") 104 (Interim Financial Reporting) and with the Statement of Recommended Practice for 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' issued in July 2022. They have also been prepared on a going concern basis and on the assumption that approval as an investment trust will continue to be granted.

?

The condensed financial statements have been prepared using the same accounting policies as the preceding annual financial statements.

 

2.

Income

?

?

?

?

Six months ended

Six months ended

?

?

31 December 2023

31 December 2022

?

?

£'000

£'000

?

Investment income

?

?

?

UK dividends

11,738

15,006

?

Overseas dividends

3,109

3,693

?

Property income dividends

252

634

?

?

15,099

19,333

?

Other income

?

?

?

Deposit interest

25

13

?

Money Market interest

538

318

?

Traded option premiums

1,695

1,205

?

Interest on tax reclaim

7

-

?

?

2,265

1,536

?

Total income

17,364

20,869

 

3.

Dividends

?

?

?

Dividends paid on Ordinary shares deducted from the revenue reserve:

?

?

?

?

?

?

?

?

Six months ended

Six months ended

?

?

31 December 2023

31 December 2022

?

?

£'000

£'000

?

2022 fourth interim dividend - 11.25p

-

13,127

?

2023 first interim dividend - 8.25p

-

9,556

?

2023 fourth interim dividend - 12.75p

14,100

-

?

2024 first interim dividend - 9.50p

10,334

-

?

Return of unclaimed dividends

-

(69)

?

?

24,434

22,614

?

?

?

?

?

The first interim dividend for 2024 of 9.50p (2023 - 8.25p) was paid on 14 December 2023 to shareholders on the register on 17 November 2023. The ex-dividend date was 16 November 2023. ? ?

?

A second interim dividend for 2024 of 9.50p (2023 - 8.25p) will be paid on 14 March 2024 to shareholders on the register on 16 February 2024. The ex-dividend date is 15 February 2024. ? ?

?

A third interim dividend for 2024 of 9.50p (2023 - 8.25p) will be paid on 13 June 2024 to shareholders on the register on 17 May 2024. The ex-dividend date is 16 May 2024. ? ?

 

4.

Management fee and finance costs

?

?

?

The management fee is as reported in the 2023 Annual Report, being a tiered fee based on net assets and calculated as follows: ? ?

?

?

?

?

?

Fee rate

Net

?

?

per annum

assets

£'million

?

0.55%

up to

350

?

0.45%

within the range

350-450

?

0.25%

greater than

450

?

?

?

?

?

The management fee and finance costs are charged 30% to revenue and 70% to capital. ? ?

5.

Taxation

?

The expense for taxation reflected in the Condensed Statement of Comprehensive Income is based on the estimated annual tax rate expected for the full financial year. The estimated annual corporation tax rate used for the year to 30 June 2024 is an effective rate of 25% (2023 - 19%).

?

During the period the Company suffered withholding tax on overseas dividend income of £191,000 (31 December 2022 - £259,000).

 

6.

Return per Ordinary share ? ? ? ?

?

?

Six months ended ?

Six months ended ?

?

?

31 December 2023 ?

31 December 2022 ?

?

?

£'000

p

£'000

p

?

Revenue return

15,554

14.2

18,967

16.3

?

Capital return

30,444

27.7

20,482

17.6

?

Total return

45,998

41.9

39,449

33.9

?

?

?

?

?

?

?

Weighted average number of Ordinary shares in issue

?

109,756,794

?

116,250,589

 

7.

Senior Loan Notes and bank loans ? ? ? ? ? ?

?

Senior Loan Notes. The Company has in issue: ? ? ? ? ? ?

?

(i) £40,000,000 of 10 year Senior Loan Notes at a fixed rate of 2.51%, redeemable at par on 8 November 2027; ? ? ? ? ? ?

?

(ii) £60,000,000 of 15 year Senior Loan Notes at a fixed rate of 4.37% redeemable at par on 8 May 2029.  ? ? ? ? ? ?

?

The Loan Notes rank pari passu and are secured by floating charges over the whole of the assets of the Company and pay interest in half yearly instalments in May and November. The Company has complied with both Note Purchase Agreements: that the ratio of net assets to gross borrowings must be greater than 3.5:1 and that net assets must not be less than £550,000,000. ? ? ? ? ? ?

?

The fair value of the Loan Notes is shown in note 9. The fair value of the 2.51% Loan Notes is calculated by aggregating the expected future cash flows discounted at a rate comprising the borrower's margin plus an average of market rates applicable to loans of a similar period of time. The fair value of the 4.37% Loan Notes is based on a comparable quoted debt security and their amortisation is presented as a finance cost, split 70% to capital and 30% to revenue. ? ? ? ? ? ?

?

?

?

?

?

?

?

?

?

?

?

?

?

?

31 December 2023

30 June 2023

?

?

?

?

?

?

£'000

£'000

?

 2.51% Senior Loan Notes  ? ? ?

?

40,000

40,000

?

 Unamortised 2.51% Senior Loan Notes issue expenses  ? ? ?

?

(52)

(59)

?

????

?

39,948

39,941

?

 4.37% Senior Loan Notes at fair value  ? ? ?

?

73,344

73,344

?

 Amortisation of 4.37% Senior Loan Note  ? ? ?

?

(4,935)

(4,144)

?

?

?

?

?

?

68,409

69,200

?

?

?

?

?

?

108,357

109,141

?

?

?

?

?

?

?

?

?

Bank loans. The Company has a three year £50 million multi-currency unsecured revolving bank credit facility with Bank of Nova Scotia Limited, committed until 27 October 2024. At the period end the Company had drawn down the facility as shown below: ? ? ? ? ? ?

?

?

?

?

?

?

?

?

?

?

31 December 2023 ? ?

30 June 2023 ? ?

?

?

Rate

Currency

£'000

Rate

Currency

£'000

?

Euro

5.04%

3,300,000

2,860

4.56%

3,300,000

2,832

?

Swiss Franc

3.05%

1,200,000

1,118

2.80%

1,200,000

1,055

?

US Dollar

6.65%

1,570,000

1,232

6.31%

1,570,000

1,235

?

Danish Krona

5.07%

6,850,000

796

4.56%

6,850,000

789

?

Norwegian Krone

5.77%

6,360,000

491

5.11%

6,360,000

467

?

?

?

?

6,497

?

?

6,378

 

8.

Share capital

?

?

?

?

?

?

Six months ended ?

Year ended ?

?

?

31 December 2023 ?

30 June 2023 ?

?

?

Shares

£'000

Shares

£'000

?

Allotted, called-up and fully paid:

?

?

?

?

?

Ordinary shares of 25p each: publicly held

108,033,782

27,008

111,720,001

27,930

?

Ordinary shares of 25p each; held in treasury

11,495,750

2,874

7,809,531

1,952

?

?

119,529,532

29,882

119,529,532

29,882

?

?

?

?

?

?

?

During the period 3,686,219 (30 June 2023 - 4,970,471) Ordinary shares were bought back for treasury at a cost of £30,540,000 (30 June 2023 - £42,202,000). As at the date of signing this report a further 640,000 shares have been bought back at a cost of £5,377,000. ? ? ? ?

9.

Net asset value per Ordinary share  ? ? ? ?

 

?

The net asset value and the net asset value attributable to the Ordinary shares at the end of the period follow. These were calculated using 108,033,782 (30 June 2023 - 111,720,001) Ordinary shares in issue at the period end (excluding treasury shares). ? ? ? ?

 

?

?

?

?

?

?

 

?

?

?

31 December 2023

?

30 June 2023

 

?

?

?

Net Asset Value

?

Net Asset Value

 

?

?

?

Attributable

?

Attributable

 

?

?

£'000

pence

£'000

pence

 

?

Net asset value - debt at par

990,208

916.6

999,184

894.4

 

?

Add: amortised cost of 2.51% Senior Loan Notes

39,948

37.0

39,941

35.8

 

?

Less: fair value of 2.51% Senior Loan Notes

(36,168)

(33.5)

(34,928)

(31.3)

 

?

Add: amortised cost of 4.37% Senior Loan Notes

68,409

63.3

69,200

61.9

 

?

Less: fair value of 4.37% Senior Loan Notes

(58,299)

(54.0)

(54,900)

(49.1)

 

?

Net asset value - debt at fair value

1,004,098

929.4

1,018,497

911.7

 

 

10.

Transaction costs

?

?

?

During the period, expenses were incurred in acquiring or disposing of investments classified at fair value through profit or loss. These have been expensed through capital and are included within gains on investments in the Condensed Statement of Comprehensive Income. The total costs were as follows: ? ?

?

?

?

?

?

?

Six months ended

Six months ended

?

?

31 December 2023

31 December 2022

?

?

£'000

£'000

?

PurchasesA

266

479

?

SalesA

55

82

?

?

321

561

?

A Costs associated with the purchases and sale of portfolio investments in the normal course of the Company's business comprising stamp duty, financial transaction taxes and brokerage. ? ?

 

11.

Fair value hierarchy ? ? ? ? ? ?

?

FRS 102 requires an entity to classify fair value measurements using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The fair value hierarchy has the following levels: ? ? ? ? ? ?

?

Level 1: unadjusted quoted prices in an active market for identical assets or liabilities that the entity can access at the measurement date; ? ? ? ? ? ?

?

Level 2: inputs other than quoted prices included within Level 1 that are observable (ie developed using market data) for the asset or liability, either directly or indirectly; and ? ? ? ? ? ?

?

Level 3: inputs are unobservable (ie for which market data is unavailable) for the asset or liability. ? ? ? ? ? ?

?

The financial assets and liabilities measured at fair value in the Condensed Statement of Financial Position are grouped into the fair value hierarchy at the reporting date as follows: ? ? ? ? ? ?

?

?

?

?

?

?

?

?

?

?

?

?

Level 1

Level 2

Level 3

Total

?

As at 31 December 2023

?

Note

£'000

£'000

£'000

£'000

?

Financial assets at fair value through profit or loss

?

?

?

?

?

?

?

Quoted equities

?

a)

1,078,543

-

-

1,078,543

?

Financial liabilities at fair value through profit or loss

?

?

?

?

?

?

?

Derivatives

?

b)

(1,165)

(206)

-

(1,371)

?

Net fair value

?

?

1,077,378

(206)

-

1,077,172

?

?

?

?

?

?

?

?

?

?

?

?

Level 1

Level 2

Level 3

Total

?

As at 30 June 2023

?

Note

£'000

£'000

£'000

£'000

?

Financial assets at fair value through profit or loss

?

?

?

?

?

?

?

Quoted equities

?

a)

1,098,311

-

-

1,098,311

?

Net fair value

?

?

1,098,311

-

-

1,098,311

?

?

?

?

?

?

?

?

?

a)

Quoted equities. The fair value of the Company's investments in quoted equities has been determined by reference to their quoted bid prices at the reporting date. Quoted equities included in Fair Value Level 1 are actively traded on recognised stock exchanges. ? ? ? ? ?

?

b)

Derivatives. The fair value of the Company's investments in Exchange Traded Options has been determined using observable market inputs on an exchange traded basis and therefore has been included in Fair Value Level 1. ? ? ? ? ?

?

?

The fair value of the Company's investments in Over the Counter Options (where the underlying equities are also held) has been determined using observable market inputs other than quoted prices of the underlying equities (which are included within Fair Value Level 1) and therefore determined as Fair Value Level 2. ? ? ? ? ?

?

?

The fair value of the 2.51% Senior Loan Notes have been calculated as £36,168,000 (30 June 2023 - £34,928,000), determined by aggregating the expected future cash flows for that loan discounted at a rate comprising the borrower's margin plus an average of market rates applicable to loans of a similar period of time, compared to carrying amortised cost of £39,948,000 (30 June 2023 - £39,941,000). ? ? ? ? ?

?

?

The fair value of the 4.37% Senior Loan Notes, have been calculated as £58,299,000 (30 June 2023 - £54,900,000), the value being based on a comparable debt security, compared to carrying amortised cost of £68,409,000 (30 June 2023 - £69,200,000). ? ? ? ? ?

?

?

All other financial assets and liabilities of the Company are included in the Condensed Statement of Financial Position at their book value which in the opinion of the Directors is not materially different from their fair value. ? ? ? ? ?

 

12.

Analysis of changes in net debt ? ? ? ? ?

?

?

At

Currency

?

Non-cash

At

?

?

30 June 2023

differences

Cash flows

movements

31 December 2023

?

?

£000

£000

£000

£000

£000

?

Cash and cash equivalents

15,115

60

9,393

-

24,568

?

Debt due within one year

(6,378)

(119)

-

-

(6,497)

?

Debt due after one year

(109,141)

-

-

784

(108,357)

?

Total

(100,404)

(59)

9,393

784

(90,286)

?

?

?

?

?

?

?

?

?

At

Currency

?

Non-cash

At

?

?

30 June 2022

differences

Cash flows

movements

31 December 2022

?

?

£000

£000

£000

£000

£'000

?

Cash and cash equivalents

20,131

875

9,853

-

30,859

?

Debt due within one year

(6,507)

(249)

91

-

(6,665)

?

Debt due after one year

(110,710)

-

-

785

(109,925)

?

?

(97,086)

626

9,944

785

(85,731)

?

An analysis of cash and cash equivalents between cash at bank and in hand and money market funds is provided in the Statement of Cash Flows.?????

?

A statement reconciling the movement in net funds to the net cash flow has not been presented as there are no differences from the above analysis. ? ? ? ? ?

13.

Transactions with the Manager

?

?

?

The Company has delegated the provision of investment management, secretarial, accounting and administration and promotional services to the Manager.  ? ?

?

The amounts charged excluding VAT for the period are set out below: ? ?

?

?

?

?

?

?

Six months ended

Six months ended

?

?

31 December 2023

31 December 2022

?

?

£'000

£'000

?

Management fees

1,838

1,887

?

Promotional activities

212

200

?

Secretarial fees

38

38

?

?

2,088

2,125

?

?

?

?

?

The amounts payable excluding VAT at the period end are set out below:

?

?

?

?

?

?

?

?

Six months ended

Six months ended

?

?

31 December 2023

31 December 2022

?

?

£'000

£'000

?

Management fees

612

635

?

Promotional activities

212

100

?

Secretarial fees

19

19

?

?

843

754

?

?

?

?

?

No fees are charged in the case of investments managed or advised by the abrdn Group. There were no commonly managed funds held in the portfolio during the six months to 31 December 2023 (2022 - none). The management agreement may be terminated by either party on the expiry of three months written notice. On termination the Manager would be entitled to receive fees which would otherwise have been due up to that date. ? ?

 

14.

Segmental information

?

The Directors are of the opinion that the Company is engaged in a single segment of business activity, being investment business. Consequently, no business segmental analysis is provided.

 

15.

The financial information in this report does not comprise statutory accounts within the meaning of Section 434 - 436 of the Companies Act 2006. The financial information for the year ended 30 June 2023 has been extracted from published accounts that have been delivered to the Registrar of Companies and on which the report of the auditors was unqualified and contained no statement under Section 498 of the Companies Act 2006.

 

16.

This Half-Yearly Financial Report was approved by the Board on 5 March 2024.

 

Alternative Performance Measures ("APMs")

 

Alternative performance measures are numerical measures of the Company's current, historical or future performance, financial position or cash flows, other than financial measures defined or specified in the applicable financial framework. The Company's applicable financial framework includes FRS 102 and the AIC SORP. The Directors assess the Company's performance against a range of criteria which are reviewed as particularly relevant for closed-end investment companies. ? ? ? ?

Discount to net asset value per Ordinary share with debt at fair value  ? ? ? ?

The discount is the amount by which the share price is lower than the net asset value per share with debt at fair value, expressed as a percentage of the net asset value.  ? ? ? ?

?

?

?

31 December 2023

30 June 2023

NAV per Ordinary share

?

a

929.4p

911.7p

Share price

?

b

865.0p

837.0p

Discount

?

(b-a)/a

(6.9%)

(8.2%)

?

?

?

?

?

Discount to net asset value per Ordinary share with debt at par value  ? ? ? ?

The discount is the amount by which the share price is lower than the net asset value per share with debt at par value, expressed as a percentage of the net asset value.  ? ? ? ?

?

?

?

31 December 2023

30 June 2023

NAV per Ordinary share

?

a

916.6p

894.4p

Share price

?

b

865.0p

837.0p

Discount

?

(b-a)/a

(5.6%)

(6.4%)

?

?

?

?

?

Dividend yield

?

?

?

?

The annual dividend per Ordinary share divided by the share price, expressed as a percentage.  ? ? ? ?

?

?

?

?

?

?

?

?

31 December 2023

30 June 2023

Dividends per share (p)

?

a

37.50p

37.50p

Share price (p)

?

b

865.0p

837.0p

Dividend yield

?

a/b

4.3%

4.5%

The dividend used for 31 December 2023 of 37.50p is presented on a historical basis and represents the amount paid in respect of the year ended 30 June 2023. ? ? ? ?

?

?

?

?

?

Net gearing

?

?

?

?

Net gearing measures the total borrowings less cash and cash equivalents dividend by shareholders' funds, expressed as a percentage. Under AIC reporting guidance cash and cash equivalents includes amounts due to and from brokers at the year end as well as cash and cash equivalents.  ? ? ? ?

?

?

?

?

?

?

?

?

31 December 2023

30 June 2023

Bank loans (£'000)

?

a

(6,497)

(6,378)

Senior Loan Notes (£'000) ?

b

(108,357)

(109,141)

Total borrowings (£'000)

?

c=a+b

(114,854)

(115,519)

Cash (£'000)

?

d

24,568

15,115

Amounts due to brokers (£'000) ?

e

(907)

(3,449)

Amounts due from brokers (£'000) ?

f

-

-

Shareholders' funds (£'000) ?

g

990,208

999,184

Net gearing

?

-(c+d+e+f)/g

9.2%

10.4%

?

?

?

?

?

Ongoing charges

?

?

?

?

The ongoing charges ratio has been calculated based on the total of investment management fees and administrative expenses less non-recurring charges and expressed as a percentage of the averge daily net asset values with debt at fair value published throughout the period. ? ? ? ?

?

?

?

?

?

?

?

?

31 December 2023

30 June 2023

Investment management feesA (£'000) ?

a

3,700

3,804

Administrative expensesA (£'000) ?

b

1,401

1,390

Less: non-recurring chargesB (£'000) ?

c

(25)

(8)

Ongoing charges (£'000)

?

a+b+c

5,076

5,186

Average net assets (£'000) ?

d

994,510

1,036,020

Ongoing charges ratio

?

(a+b+c)/d

0.51%

0.50%

A 31 December 2023 represents the annualised forecast to 30 June 2024.  ? ? ? ?

B 31 December 2023 comprises £20,000 Directors recruitment fee, £1,500 relating to legal fees and £3,250 relating to other professional services unlikely to recur. 30 June 2023 comprises £7,000 profesisonal fees relating to discussions with the registrar and £1,000 quick turnaround fee for electronic filing of statutory statements. ? ? ? ?

?

?

?

?

?

The ongoing charges ratio provided in the Company's Key Information Document is calculated in line with the PRIIPs regulations, which includes financing and transaction costs.  ? ? ? ?

Total return

?

?

?

?

Share price and NAV total returns show how the NAV and share price has performed over a period of time in percentage terms, taking into account both capital returns and dividends paid to shareholders. Share price and NAV total returns are monitored against open-ended and closed-ended competitors, and the FTSE All-Share Index, respectively.  ? ? ? ?

?

?

?

?

?

?

?

Share

NAV

NAV

Six months ended 31 December 2023

?

price

(debt at fair value)

(debt at par)

Opening at 1 July 2023

a

837.0p

911.7p

894.4p

Closing at 31 December 2023

b

865.0p

929.4p

916.6p

Price movements

c=(b/a)-1

3.3%

1.9%

2.5%

Dividend reinvestmentA

d

2.9%

2.6%

2.7%

Total return

c+d

6.2%

4.5%

5.2%

?

?

?

?

?

?

?

?

?

?

?

?

Share

NAV

NAV

Year ended 30 June 2023

?

price

(debt at fair value)

(debt at par)

Opening at 1 July 2022

a

832.0p

871.0p

864.9p

Closing at 30 June 2023

b

837.0p

911.7p

894.4p

Price movements

c=(b/a)-1

0.6%

4.7%

3.4%

Dividend reinvestmentA

d

4.3%

4.1%

4.1%

Total return

c+d

4.9%

8.8%

7.5%

A Share price total return involves reinvesting the net dividend in the share price of the Company on the date on which that dividend goes ex-dividend. NAV total return involves investing the net dividend in the NAV of the Company with debt at fair value on the date on which that dividend goes ex-dividend.  ? ? ? ?

 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BUGDXDBGDGSU
Date   Source Headline
26th Apr 20245:28 pmRNSTransaction in Own Shares
26th Apr 202412:45 pmRNSNet Asset Value(s)
25th Apr 20245:31 pmRNSTransaction in Own Shares
25th Apr 20241:27 pmRNSNet Asset Value(s)
24th Apr 20245:48 pmRNSTransaction in Own Shares
24th Apr 202412:11 pmRNSNet Asset Value(s)
23rd Apr 202412:47 pmRNSNet Asset Value(s)
22nd Apr 20245:17 pmRNSTransaction in Own Shares
22nd Apr 20242:04 pmRNSGearing disclosure
22nd Apr 202412:24 pmRNSNet Asset Value(s)
19th Apr 20245:26 pmRNSTransaction in Own Shares
19th Apr 202412:46 pmRNSNet Asset Value(s)
18th Apr 20245:16 pmRNSTransaction in Own Shares
18th Apr 202412:36 pmRNSNet Asset Value(s)
17th Apr 20245:34 pmRNSTransaction in Own Shares
17th Apr 202412:08 pmRNSNet Asset Value(s)
16th Apr 20245:11 pmRNSTransaction in Own Shares
16th Apr 20241:00 pmRNSNet Asset Value(s)
15th Apr 20245:43 pmRNSPortfolio Disclosures
15th Apr 20245:14 pmRNSTransaction in Own Shares
15th Apr 20243:27 pmRNSGearing Disclosures
15th Apr 202412:50 pmRNSNet Asset Value(s)
15th Apr 20248:55 amEQSEdison issues update on Murray Income Trust (MUT): Delivering income and capital growth
12th Apr 20245:29 pmRNSTransaction in Own Shares
12th Apr 202412:56 pmRNSNet Asset Value(s)
11th Apr 20245:34 pmRNSTransaction in Own Shares
11th Apr 202412:42 pmRNSNet Asset Value(s)
10th Apr 20245:31 pmRNSTransaction in Own Shares
10th Apr 202412:53 pmRNSNet Asset Value(s)
9th Apr 20245:25 pmRNSTransaction in Own Shares
9th Apr 202412:00 pmRNSNet Asset Value(s)
8th Apr 20245:29 pmRNSTransaction in Own Shares
8th Apr 20242:46 pmRNSGearing disclosure
8th Apr 20241:00 pmRNSNet Asset Value(s)
5th Apr 202412:36 pmRNSHolding(s) in Company
5th Apr 202412:33 pmRNSNet Asset Value(s)
4th Apr 20245:15 pmRNSTransaction in Own Shares
4th Apr 202412:47 pmRNSNet Asset Value(s)
3rd Apr 20245:22 pmRNSTransaction in Own Shares
3rd Apr 20245:20 pmRNSQuarterly disclosure
3rd Apr 202412:47 pmRNSNet Asset Value(s)
2nd Apr 20245:19 pmRNSTransaction in Own Shares
2nd Apr 20243:33 pmRNSGearing disclosure
2nd Apr 202410:06 amRNSTotal Voting Rights
28th Mar 20245:43 pmRNSTransaction in Own Shares
28th Mar 20243:15 pmRNSNet Asset Value(s)
27th Mar 20245:25 pmRNSTransaction in Own Shares
27th Mar 202412:19 pmRNSNet Asset Value(s)
26th Mar 20245:17 pmRNSTransaction in Own Shares
26th Mar 202412:24 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.